Admitted local publications that cite Comments on “Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease”.
No admitted local citation edges point to this work yet.
Cited by — Comments on “Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease” | ResearchHub - ResearchHub
